Adjunct Immune Globulin for Vaccine-Induced Immune Thrombotic Thrombocytopenia

Share this page:

Title

Adjunct Immune Globulin for Vaccine-Induced Immune Thrombotic Thrombocytopenia

Description

The use of high-dose intravenous immune globulin (IVIG) plus anticoagulation is recommended for the treatment of vaccine-induced immune thrombotic thrombocytopenia (VITT), a rare side effect of adenoviral vector vaccines against coronavirus disease 2019 (Covid-19).

Date Last Updated (Year-Month-Day)

2021-08-19

Citation

Bourguignon, Alex, Donald M. Arnold, Theodore E. Warkentin, James W. Smith, Tania Pannu, Jeffrey M. Shrum, Zainab A. A. Al Maqrashi, Anjali Shroff, Marie-Claude Lessard, Normand Blais, John G. Kelton, and Ishac Nazy. 2021. "Adjunct Immune Globulin for Vaccine-Induced Immune Thrombotic Thrombocytopenia." New England Journal of Medicine 385 (8):720-8.

Accessibility

Free online on NEJM.